Correlation Between Vaxcyte and Codexis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Codexis, you can compare the effects of market volatilities on Vaxcyte and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Codexis.

Diversification Opportunities for Vaxcyte and Codexis

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vaxcyte and Codexis is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Vaxcyte i.e., Vaxcyte and Codexis go up and down completely randomly.

Pair Corralation between Vaxcyte and Codexis

Given the investment horizon of 90 days Vaxcyte is expected to under-perform the Codexis. But the stock apears to be less risky and, when comparing its historical volatility, Vaxcyte is 1.74 times less risky than Codexis. The stock trades about -0.21 of its potential returns per unit of risk. The Codexis is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  382.00  in Codexis on October 6, 2024 and sell it today you would earn a total of  161.00  from holding Codexis or generate 42.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy97.62%
ValuesDaily Returns

Vaxcyte  vs.  Codexis

 Performance 
       Timeline  
Vaxcyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Codexis 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vaxcyte and Codexis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaxcyte and Codexis

The main advantage of trading using opposite Vaxcyte and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.
The idea behind Vaxcyte and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity